ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

97 hedge funds and large institutions have $58.1M invested in Aclaris Therapeutics in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 38 reducing their positions, and 24 closing their positions.

Holders
97
Holders Change
–
Holders Change %
0%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
20
Reduced
38
Closed
24
Calls
$51K
Puts
$4K
Net Calls
+$47K
Net Calls Change
+$65K

Top Buyers

1
BCM
1
BML Capital Management
Indiana
$14.3M
2
SCM
2
Stonepine Capital Management
Oregon
$2.12M
3
TC
3
Trium Capital
United Kingdom
$2.08M
4
AC
4
Aldebaran Capital
Indiana
$944K
5
Goldman Sachs
5
Goldman Sachs
New York
$1.01M

Top Sellers

1
BlackRock
1
BlackRock
New York
$2.24M
2
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$1.1M
3
State Street
3
State Street
Massachusetts
$216K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$852K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.01M
Name Market Value Shares Shares
Change 		Shares
Change %
BCM
1
BML Capital Management
Indiana
$14.3M 12,988,134 +3,592,200 +38%
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.16M 4,687,551 -242,224 -5%
Millennium Management
3
Millennium Management
New York
$3.67M 3,336,850 +63,358 +2%
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$3.65M 3,320,206 +37,224 +1%
RSCM
5
Rock Springs Capital Management
Maryland
$3.03M 2,753,495 – –
BlackRock
6
BlackRock
New York
$2.24M 2,032,155 -3,169,992 -61%
SCM
7
Stonepine Capital Management
Oregon
$2.12M 1,927,446 +1,927,446 New
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$2.1M 1,913,449 -221,918 -10%
TC
9
Trium Capital
United Kingdom
$2.08M 1,892,050 +1,892,050 New
Two Sigma Advisers
10
Two Sigma Advisers
New York
$1.58M 1,436,900 -14,200 -1%
Two Sigma Investments
11
Two Sigma Investments
New York
$1.22M 1,113,072 -216,544 -16%
BCLSI
12
Bain Capital Life Sciences Investors
Massachusetts
$1.1M 1,000,000 -2,000,000 -67%
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$1.03M 940,752 -271,508 -22%
Deutsche Bank
14
Deutsche Bank
Germany
$1.02M 923,313 -33,708 -4%
Renaissance Technologies
15
Renaissance Technologies
New York
$1.01M 922,200 -751,200 -45%
Goldman Sachs
16
Goldman Sachs
New York
$1.01M 916,620 +770,808 +529%
Citadel Advisors
17
Citadel Advisors
Florida
$963K 875,216 -54,787 -6%
AC
18
Aldebaran Capital
Indiana
$944K 858,152 +858,152 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$852K 774,137 -790,917 -51%
SB
20
Samsara BioCapital
California
$766K 696,171 – –
Fidelity Investments
21
Fidelity Investments
Massachusetts
$758K 689,353 +17,525 +3%
PAI
22
Palo Alto Investors
California
$627K 569,832 – –
Northern Trust
23
Northern Trust
Illinois
$573K 520,469 -41,755 -7%
AI
24
Acuitas Investments
Washington
$511K 464,120 +2,457 +0.5%
ACM
25
Aisling Capital Management
New York
$478K 434,455 – –
1
2 3 4 5